tiprankstipranks
Maravai LifeSciences Restructures Leadership Amid Revenue Update
PremiumCompany AnnouncementsMaravai LifeSciences Restructures Leadership Amid Revenue Update
2M ago
Maravai sees 2024 revenue at midpoint of $255M-$265M range
Premium
The Fly
Maravai sees 2024 revenue at midpoint of $255M-$265M range
2M ago
Maravai Lifesciences initiated with a Neutral at Guggenheim
Premium
The Fly
Maravai Lifesciences initiated with a Neutral at Guggenheim
2M ago
Maravai Lifesciences price target lowered to $7 from $10 at Morgan Stanley
PremiumThe FlyMaravai Lifesciences price target lowered to $7 from $10 at Morgan Stanley
3M ago
Nvidia trades on Dow for first time, Rivian reports downbeat Q3: Morning Buzz
Premium
The Fly
Nvidia trades on Dow for first time, Rivian reports downbeat Q3: Morning Buzz
4M ago
Maravai Lifesciences price target lowered to $13 from $17 at RBC Capital
Premium
The Fly
Maravai Lifesciences price target lowered to $13 from $17 at RBC Capital
4M ago
Maravai Lifesciences lowers FY24 revenue view to $255M-$265M from $265M-$285M
PremiumThe FlyMaravai Lifesciences lowers FY24 revenue view to $255M-$265M from $265M-$285M
4M ago
Maravai Lifesciences to acquire DNA and RNA business of Officinae Bio
Premium
The Fly
Maravai Lifesciences to acquire DNA and RNA business of Officinae Bio
4M ago
Codexis licenses genomics life science enzyme portfolio to Alphazyme
Premium
The Fly
Codexis licenses genomics life science enzyme portfolio to Alphazyme
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100